The shares of Biomerica Inc. (NASDAQ:BMRA) has been pegged with a rating of Buy by B. Riley FBR Inc. in its latest research note that was published on January 04, 2018. The Healthcare company has also assigned a $7.50 price target. B. Riley FBR Inc. wasn’t the only research firm that published a report of Biomerica Inc., with other equities research analysts also giving their opinion on the stock.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 0 believe it has the potential for further growth, thus rating it as Hold while 1 advised investors to purchase the stock. The consensus currently stands at a Buy while its average price target is $6.25. The price of the stock the last time has raised by 239.02% from its 52-Week high price while it is -70.29% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 54.78.
The shares of the company dipped by -4.40% during the trading session on Wednesday, reaching a low of $6.86 while ending the day at $6.95. During the trading session, a total of 1.37 million shares were traded which represents a -18.39% decline from the average session volume which is 1.16 million shares. BMRA had ended its last session trading at $7.27. Biomerica Inc. debt-to-equity ratio currently stands at 0.00, while its quick ratio hovers at 1.20 BMRA 52-week low price stands at $2.05 while its 52-week high price is $23.39.
The company in its last quarterly report recorded -$0.05 earnings per share which is above the predicted by most analysts. The Biomerica Inc. generated 851000.0 in revenue during the last quarter. In the second quarter last year, the firm recorded -$0.05 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -40.0%. Biomerica Inc. has the potential to record -0.24 EPS for the current fiscal year, according to equities analysts.
Investment analysts at TD Securities published a research note on March 20, 2020 where it informed investors and clients that Bank of Montreal (NYSE:BMO) is now rated as Buy. Even though the stock has been trading at $44.36/share, analysts expect it to surge by 8.75% to reach $85.95/share. It started the day trading at $51.35 and traded between $44.89 and $48.24 throughout the trading session.
A look at its technical shows that BMO’s 50-day SMA is 67.74 while its 200-day SMA stands at 72.70. The stock has a high of $79.93 for the year while the low is $38.31. The stock, however, witnessed a rise in its short on 03/13/20. Compared to previous close which recorded 5.91 M shorted shares, the short percentage went higher by 49.84%, as 8.86M BMRA shares were shorted. At the moment, only 0.85% of Bank of Montreal shares were sold short. The company’s P/E ratio currently sits at 7.99, while the P/B ratio is 0.96. The company’s average trading volume currently stands at 811.17K shares, which means that the short-interest ratio is just 6.69 days. Over the past seven days, the company moved, with its shift of 18.29%. Looking further, the stock has dropped -37.35% over the past 90 days while it lost -33.49% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The RBC Global Asset Management, Inc. bought more BMO shares, increasing its portfolio by 0.53% during the last quarter. This move now sees The RBC Global Asset Management, Inc. purchasing 210,679 shares in the last quarter, thus it now holds 39,762,859 shares of BMO, with a total valuation of $2,699,102,869. TD Asset Management, Inc. meanwhile sold more BMO shares in the recently filed quarter, changing its stake to $1,320,453,756 worth of shares.
Similarly, BMO Asset Management, Inc. increased its Bank of Montreal shares by 2.78% during the recently filed quarter. After buying 18,406,028 shares in the last quarter, the firm now controls 497,819 shares of Bank of Montreal which are valued at $1,249,401,181. In the same vein, The Vanguard Group, Inc. increased its Bank of Montreal shares by during the most recent reported quarter. The firm bought 162,820 shares during the quarter which increased its stakes to 17,930,416 shares and is now valued at $1,217,116,638. Following these latest developments, around 0.10% of Bank of Montreal stocks are owned by institutional investors and hedge funds.